Dr. Gorav Ailawadi
Claim this profileUniversity of Michigan
Affiliated Hospitals
University Of Michigan
University Of Michigan Hospital And Health Systems
Clinical Trials Gorav Ailawadi is currently running
Cephea Valve System
for Mitral Regurgitation
This trial is testing a new device called the Cephea Mitral Valve System that can fix or replace a damaged heart valve using a thin tube. It aims to help patients with mitral valve disease who need a less invasive treatment than open-heart surgery. The Cephea Mitral Valve System is a new technology developed by Cephea Valve Technologies, aiming to treat severe mitral regurgitation through a less invasive approach.
Recruiting
1 award
N/A
Percutaneous vs Surgical Repair
for Mitral Valve Regurgitation
This is a prospective, multicenter, open-label, randomized trial comparing mitral valve (MV) transcatheter edge-to-edge repair (TEER) to surgical repair (1:1 ratio) in patients with primary, degenerative mitral regurgitation (MR). The trial will be conducted in the U.S., Canada, Germany, Spain, Belgium and the United Kingdom, and is designed as a strategy trial. Thus, all devices legally marketed for TEER of primary degenerative MR in a particular country are eligible to be used in this trial.
Recruiting
1 award
N/A
5 criteria
More about Gorav Ailawadi
Clinical Trial Related
7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Gorav Ailawadi has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Transcatheter Tricuspid Valve Replacement
- MitraClip System
- Tendyne Mitral Valve System
- MitraClip™ Device Implantation
Breakdown of trials Gorav Ailawadi has run
Mitral Regurgitation
Mitral Valve Regurgitation
Valvular Heart Disease
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gorav Ailawadi specialize in?
Gorav Ailawadi focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Gorav Ailawadi currently recruiting for clinical trials?
Yes, Gorav Ailawadi is currently recruiting for 6 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Gorav Ailawadi has studied deeply?
Yes, Gorav Ailawadi has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, Transcatheter Tricuspid Valve Replacement.
What is the best way to schedule an appointment with Gorav Ailawadi?
Apply for one of the trials that Gorav Ailawadi is conducting.
What is the office address of Gorav Ailawadi?
The office of Gorav Ailawadi is located at: University of Michigan, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.